Published in Infect Immun on August 01, 2002
A periciliary brush promotes the lung health by separating the mucus layer from airway epithelia. Science (2012) 2.98
The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles. Biomaterials (2009) 1.54
Comparative analysis of plant and animal models for characterization of Burkholderia cepacia virulence. Infect Immun (2003) 1.41
Responses of well-differentiated airway epithelial cell cultures from healthy donors and patients with cystic fibrosis to Burkholderia cenocepacia infection. Infect Immun (2004) 1.25
A decade of Burkholderia cenocepacia virulence determinant research. Infect Immun (2010) 1.22
Cystic fibrosis-niche adaptation of Pseudomonas aeruginosa reduces virulence in multiple infection hosts. PLoS One (2012) 1.20
Attenuated virulence of a Burkholderia cepacia type III secretion mutant in a murine model of infection. Infect Immun (2003) 1.15
Quorum-sensing mutations affect attachment and stability of Burkholderia cenocepacia biofilms. Appl Environ Microbiol (2005) 1.13
Localization of Burkholderia cepacia complex bacteria in cystic fibrosis lungs and interactions with Pseudomonas aeruginosa in hypoxic mucus. Infect Immun (2014) 1.00
A type IV secretion system contributes to intracellular survival and replication of Burkholderia cenocepacia. Infect Immun (2008) 0.97
Insights into the role of extracellular polysaccharides in Burkholderia adaptation to different environments. Front Cell Infect Microbiol (2011) 0.91
Distribution and expression of the ZmpA metalloprotease in the Burkholderia cepacia complex. J Bacteriol (2005) 0.90
In vitro activities of a novel nanoemulsion against Burkholderia and other multidrug-resistant cystic fibrosis-associated bacterial species. Antimicrob Agents Chemother (2008) 0.90
Insights into cross-kingdom plant pathogenic bacteria. Genes (Basel) (2011) 0.89
Comparison of antibiotic susceptibility of Burkholderia cepacia complex organisms when grown planktonically or as biofilm in vitro. Eur J Clin Microbiol Infect Dis (2007) 0.88
Disruption of tight junctions during traversal of the respiratory epithelium by Burkholderia cenocepacia. Infect Immun (2005) 0.88
Clinical and environmental Burkholderia strains: biofilm production and intracellular survival. Curr Microbiol (2007) 0.86
Mechanisms of Disease: Host-Pathogen Interactions between Burkholderia Species and Lung Epithelial Cells. Front Cell Infect Microbiol (2015) 0.83
Host evasion by Burkholderia cenocepacia. Front Cell Infect Microbiol (2012) 0.82
The tyrosine kinase BceF and the phosphotyrosine phosphatase BceD of Burkholderia contaminans are required for efficient invasion and epithelial disruption of a cystic fibrosis lung epithelial cell line. Infect Immun (2014) 0.81
Role of actin filament network in Burkholderia multivorans invasion in well-differentiated human airway epithelia. Infect Immun (2003) 0.80
Linocin and OmpW Are Involved in Attachment of the Cystic Fibrosis-Associated Pathogen Burkholderia cepacia Complex to Lung Epithelial Cells and Protect Mice against Infection. Infect Immun (2016) 0.79
Potential mechanisms underlying the acute lung dysfunction and bacterial extrapulmonary dissemination during Burkholderia cenocepacia respiratory infection. Respir Res (2010) 0.78
Burkholderia cepacia Complex Vaccines: Where Do We Go from here? Vaccines (Basel) (2016) 0.75
Bacterial biofilms: a common cause of persistent infections. Science (1999) 40.82
Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr (1984) 9.61
Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell (1998) 6.72
Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest (2002) 6.35
Burkholderia cepacia: medical, taxonomic and ecological issues. J Med Microbiol (1996) 4.11
Taxonomy and identification of the Burkholderia cepacia complex. J Clin Microbiol (2001) 4.02
The cep quorum-sensing system of Burkholderia cepacia H111 controls biofilm formation and swarming motility. Microbiology (2001) 3.37
The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nat Med (1995) 3.36
Differentiation of Burkholderia species by PCR-restriction fragment length polymorphism analysis of the 16S rRNA gene and application to cystic fibrosis isolates. J Clin Microbiol (1999) 2.87
Quorum sensing in Burkholderia cepacia: identification of the LuxRI homologs CepRI. J Bacteriol (1999) 2.81
Identification and population structure of Burkholderia stabilis sp. nov. (formerly Burkholderia cepacia genomovar IV). J Clin Microbiol (2000) 2.63
Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis. Am J Respir Crit Care Med (2001) 2.55
N-acylhomoserine-lactone-mediated communication between Pseudomonas aeruginosa and Burkholderia cepacia in mixed biofilms. Microbiology (2001) 2.51
Mucin gene expression during differentiation of human airway epithelia in vitro. Muc4 and muc5b are strongly induced. Am J Respir Cell Mol Biol (1999) 2.10
Burkholderia anthina sp. nov. and Burkholderia pyrrocinia, two additional Burkholderia cepacia complex bacteria, may confound results of new molecular diagnostic tools. FEMS Immunol Med Microbiol (2002) 1.86
Invasion of respiratory epithelial cells by Burkholderia (Pseudomonas) cepacia. Infect Immun (1996) 1.82
Binding of Pseudomonas cepacia to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis. J Clin Invest (1992) 1.80
Role of commensal relationships on the spatial structure of a surface-attached microbial consortium. Environ Microbiol (2000) 1.76
Invasion and intracellular survival of Burkholderia cepacia. Infect Immun (2000) 1.74
Complete sequence of the human mucin MUC4: a putative cell membrane-associated mucin. Biochem J (1999) 1.67
Role of the cytoskeleton in calcium signaling in NIH 3T3 cells. An intact cytoskeleton is required for agonist-induced [Ca2+]i signaling, but not for capacitative calcium entry. J Biol Chem (1997) 1.59
Intracellular survival of Burkholderia cepacia complex isolates in the presence of macrophage cell activation. Microbiology (1999) 1.51
Pathogenicity of microbes associated with cystic fibrosis. Microbes Infect (1999) 1.50
Retargeting the coxsackievirus and adenovirus receptor to the apical surface of polarized epithelial cells reveals the glycocalyx as a barrier to adenovirus-mediated gene transfer. J Virol (2000) 1.45
Paracytosis of Haemophilus influenzae through cell layers of NCI-H292 lung epithelial cells. Infect Immun (1995) 1.21
Immunolocalisation of Burkholderia cepacia in the lungs of cystic fibrosis patients. J Med Microbiol (2001) 1.19
Increasing resistance of planktonic and biofilm cultures of Burkholderia cepacia to ciprofloxacin and ceftazidime during exponential growth. J Antimicrob Chemother (1998) 1.10
Helicobacter pylori: I. Ultrastructural sequences of adherence, attachment, and penetration into the gastric mucosa. Ultrastruct Pathol (1995) 1.05
Invasion of human type II pneumocytes by Burkholderia cepacia. Microb Pathog (2001) 0.99
A novel mucin-sulphatase activity found in Burkholderia cepacia and Pseudomonas aeruginosa. J Med Microbiol (1999) 0.97
An outbreak of Burkholderia cepacia bacteremia in hemodialysis patients: an epidemiologic and molecular study. Am J Kidney Dis (2000) 0.95
Pathogenesis of bacterial bronchitis in cystic fibrosis. Pediatr Infect Dis J (1997) 0.92
Generation of a reproducible nutrient-depleted biofilm of Escherichia coli and Burkholderia cepacia. J Appl Microbiol (1998) 0.83
Mucinase activity. Methods Mol Biol (2000) 0.78
The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell (2002) 20.11
NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity (2004) 13.55
NALPs: a novel protein family involved in inflammation. Nat Rev Mol Cell Biol (2003) 4.08
Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. Am J Respir Crit Care Med (2008) 3.91
Tollip regulates proinflammatory responses to interleukin-1 and lipopolysaccharide. Mol Cell Biol (2006) 2.33
Characterization of wild-type and deltaF508 cystic fibrosis transmembrane regulator in human respiratory epithelia. Mol Biol Cell (2005) 2.13
Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis. J Cyst Fibros (2010) 1.93
A bacterial cell to cell signal in the lungs of cystic fibrosis patients. FEMS Microbiol Lett (2002) 1.72
What is the current role of algorithmic approaches for diagnosis of Clostridium difficile infection? J Clin Microbiol (2010) 1.70
Characterization of Staphylococcus aureus cutaneous infections in a pediatric dermatology tertiary health care outpatient facility. J Am Acad Dermatol (2010) 1.50
High prevalence of respiratory ciliary dysfunction in congenital heart disease patients with heterotaxy. Circulation (2012) 1.44
Regulation of MUC5AC mucin secretion and airway surface liquid metabolism by IL-1beta in human bronchial epithelia. Am J Physiol Lung Cell Mol Physiol (2003) 1.26
The DeltaF508 mutation results in loss of CFTR function and mature protein in native human colon. Gastroenterology (2004) 1.25
Intracellular trafficking of interleukin-1 receptor I requires Tollip. Curr Biol (2006) 1.18
Metabolic syndrome signs in Wistar rats submitted to different high-fructose ingestion protocols. Br J Nutr (2008) 1.13
Primary ciliary dyskinesia and newborn respiratory distress. Semin Perinatol (2006) 1.11
Ion and fluid transport properties of small airways in cystic fibrosis. Am J Respir Crit Care Med (2006) 1.01
Increased susceptibility of purinergic receptor-deficient mice to lung infection with Pseudomonas aeruginosa. Am J Physiol Lung Cell Mol Physiol (2005) 0.96
Cystic fibrosis: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases. Ann Am Thorac Soc (2014) 0.92
A heterozygous mutation disrupting the SPAG16 gene results in biochemical instability of central apparatus components of the human sperm axoneme. Biol Reprod (2007) 0.91
Detection of rapidly growing mycobacteria in routine cultures of samples from patients with cystic fibrosis. J Clin Microbiol (2011) 0.90
Comparison of interferon-gamma release assay and tuberculin test for screening in healthcare workers. Rev Port Pneumol (2010) 0.90
Exercise at anaerobic threshold intensity and insulin secretion by isolated pancreatic islets of rats. Islets (2010) 0.86
Ubiquitination of the Epstein-Barr virus-encoded latent membrane protein 1 depends on the integrity of the TRAF binding site. Oncogene (2003) 0.86
Printing nearly-discrete magnetic patterns using chemical disorder induced ferromagnetism. Nano Lett (2014) 0.85
Tuberculosis drug resistance and outcomes among tuberculosis inpatients in Lilongwe, Malawi. Malawi Med J (2012) 0.84
Impact of early fructose intake on metabolic profile and aerobic capacity of rats. Lipids Health Dis (2011) 0.83
Different exercise protocols improve metabolic syndrome markers, tissue triglycerides content and antioxidant status in rats. Diabetol Metab Syndr (2011) 0.82
Effects of exercise training on hippocampus concentrations of insulin and IGF-1 in diabetic rats. Hippocampus (2009) 0.82
Aerobic capacity of rats recovered from fetal malnutrition with a fructose-rich diet. Appl Physiol Nutr Metab (2010) 0.81
Recovery of rat growth and lipid profiles in adult rats subjected to fetal protein malnutrition with a fructose-rich diet. Nutr Res (2010) 0.80
Mycobacterium chelonae canaliculitis associated with SmartPlug use. Ophthal Plast Reconstr Surg (2008) 0.79
Exercise training in the aerobic/anaerobic metabolic transition prevents glucose intolerance in alloxan-treated rats. BMC Endocr Disord (2008) 0.79
Metabolic syndrome markers in wistar rats of different ages. Diabetol Metab Syndr (2012) 0.78
Tuberculosis - Risk of continued transmission in healthcare workers. Rev Port Pneumol (2010) 0.78
Creatine supplementation and oxidative stress in rat liver. J Int Soc Sports Nutr (2013) 0.78
ATS Consensus Statement: Research opportunities and challenges in pediatric pulmonology. Am J Respir Crit Care Med (2005) 0.77
A new approach to counteract bacteria resistance: a comparative study between moxifloxacin and a new moxifloxacin derivative in different model systems of bacterial membrane. Chem Biol Drug Des (2012) 0.77
[Epidemiological profile of the clientele in HIV Testing and Counseling Centers in Santa Catarina State, Brazil, 2005]. Cad Saude Publica (2008) 0.76
Should interferon gamma release assays become the standard method for screening patients for Mycobacterium tuberculosis infections in the United States? J Clin Microbiol (2011) 0.75
Resource-Efficient High-Yield Ionothermal Synthesis of Microcrystalline Cu3-xP. Inorg Chem (2016) 0.75
[The burnout syndrome]. Servir (2002) 0.75
Introduction: primary ciliary dyskinesia and overlapping syndromes. Proc Am Thorac Soc (2011) 0.75
[Acute penetrating atherosclerotic ulcers in aortic arch: differential diagnosis of chest pain]. Rev Port Cir Cardiotorac Vasc (2013) 0.75
Is there a gender shift in HCV infection? Int J Infect Dis (2005) 0.75
Dihydropteroate synthase (DHPS) genotyping by PCR-RFLP analysis of Pneumocystis jirovecii repeated isolates from HIV-infected patients: a preliminary study. J Eukaryot Microbiol (2003) 0.75